Reach Us +1-218-451-2974


Circulating Cytokines In Patients Undergoing Tonsillectomy With Fibrin Glue | 12395
ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

7th European Otolaryngology-ENT Surgery Conference

Vienna, Austria
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
Share This Page

Circulating cytokines in patients undergoing tonsillectomy with fibrin glue

International Conference and Exhibition on Otolaryngology

L. Stiller-Timor, A.D. Goldbart, N. Segal M.D, A. Amash3, M. Huleihel, A. Leiberman, A. Tal, G. Holcberg and M. Puterman

ScientificTracks Abstracts: Otolaryngology

DOI: 10.4172/2161-119X.S1.002

Objective: Fibrin glue is used as a haemostatic agent or as a sealant. The aim of this study is to objectively evaluate the efficacy of the use of fibrin glue Quixil � a human surgical sealer � in tonsillectomy, for the reduction of post-operative inflammatory response. Study design: A prospective randomized single-blind study. Methods: The study was performed on 40 consecutive patients undergoing adenotonsillectomy (T&A). Patients were randomly assigned to one of two sub-groups: a study group and a control group. The tonsillar beds of patients in the study group were coated with fibrin glue (Quixil, OMRIX biopharmaceuticals) at the end of the operation; the patients in the control group were treated for hemostasis without the use of fibrin glue. Complete blood counts and circulating pro-inflammatory cytokines (assayed by specific immunoassay � ELISA) were assessed in samples drawn pre- and 16 hours post-tonsillectomy. Results: Forty patients (aged 5.8�2.4 y) were consecutively enrolled; 45% (18) of the patients were treated with fibrin glue, 55% (22) were not. Compared to controls, Quixil-treated patients demonstrated a reduction in post-tonsillectomy circulating leukocytes (29.2% vs. 45.4%, p<0.05), neutrophiles (28.3% vs. 42.1%, p<0.05), IL-6 (+1% vs. +42%, p<0.05), and TNF-alpha (+8% vs. +26%, p<0.05. Conclusions: Intra-operative fibrin glue therapy is associated with decreased immediate inflammatory response following T&A. Further studies are warranted to assess long term outcome. Level of evidence: 1B